Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal hormone therapy: the pros and cons.

L M Rivera-Woll1, S R Davis

  • 1The Jean Hailes Foundation, National Health and Medical Research Council Centre of Clinical Research Excellence, Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia.

Internal Medicine Journal
|March 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in farm management factors on New Zealand dairy farms with divergent bulk milk urea concentration.

Journal of dairy science·2026
Same author

Behavioral and physiological responses to short-term cold exposure in calves carrying the SLICK1 allele.

Journal of dairy science·2026
Same author

The relative milk production of dairy cattle in tropical Costa Rica that are heterozygous and homozygous for the SLICK1 allele.

JDS communications·2025
Same author

Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study.

Climacteric : the journal of the International Menopause Society·2024
Same author

The 2023 Practitioner's Toolkit for Managing Menopause.

Climacteric : the journal of the International Menopause Society·2023
Same author

Testosterone and the heart: friend or foe?

Climacteric : the journal of the International Menopause Society·2023

Postmenopausal hormone therapy (HT) use is debated after recent trials. Individualized assessment of symptoms and risks is crucial, as trial results may not apply to all HT use.

Area of Science:

  • Menopause management
  • Endocrinology
  • Women's health

Background:

  • Postmenopausal hormone therapy (HT) use is under scrutiny following large randomized controlled trials.
  • Recent trial results necessitate a re-evaluation of HT prescribing practices.
  • Understanding individual patient symptomatology and long-term illness risk is paramount.

Purpose of the Study:

  • To reassess the current understanding of postmenopausal hormone therapy (HT) benefits and risks.
  • To highlight the need for individualized treatment decisions in HT use.
  • To clarify the limitations of extrapolating recent trial findings to general HT application.

Main Methods:

  • Review of recent large randomized controlled trials on hormone therapy.
  • Analysis of specific HT regimens and study group characteristics.

Related Experiment Videos

  • Synthesis of evidence regarding definite benefits, risks, and areas of uncertainty.

    • Main Results:

    • Recent trials have generated significant debate regarding postmenopausal hormone therapy (HT).
    • Specific HT regimens and study populations limit the generalizability of trial conclusions.
    • Clear areas of benefit and risk exist, alongside considerable uncertainty.

    Conclusions:

    • Physicians must individually assess each woman's symptomatology and risk profile for long-term illnesses when considering HT.
    • Conclusions from recent randomized controlled trials cannot be universally extrapolated to all postmenopausal hormone therapy use.
    • A nuanced approach is required, balancing known benefits and risks with areas of uncertainty in HT management.